Protect and commercialize your IP
Clark+Elbing advises life science, chemistry, and device innovators on the best strategies to protect and extend their intellectual property (IP) assets, evaluate litigation risks, and avoid conflicts with the IP rights of others. We provide a comprehensive IP strategy, including development, protection, portfolio management, and transactions, so you can achieve your business goals. We not only work to protect your products directly but also develop strategies to keep competitors out of your market. Our IP counsel spans:
- Corporate & Investment Diligence
- Licensing & Transactions
- Patent Opinions
- Patent Prosecution
- Trade Secrets
- Trademarks
First-hand knowledge and first-rate counseling
With extensive technical and legal experience, we understand the IP opportunities and challenges confronting today’s technology sector, particularly those involving life science, chemistry, and devices. Clients trust our science background and thorough understanding of the applicable legal principles to guide them through a complex, global IP landscape in technology areas including:
- Antibodies
- Biomarkers
- Biomaterials
- Cardiovascular devices
- Cell-based therapies
- Ceramics
- Chemical and biological reactors
- Chemical processes
- Coatings
- Consumer products
- Cosmetics
- Dental devices
- Devices for improving urogenital and gastrointestinal health
- Diagnostic devices
- Diagnostics
- Dialysis components
- Drug delivery devices
- Drug delivery systems
- Drug formulations
- Drug-device combination products
- Drug-eluting stents
- EEG headsets
- Electronics and semiconductor materials
- Environmental monitoring
- Food and beverage equipment
- Food processing
- Gene therapy
- Genetically-modified animals
- Genomics
- Green/clean energy technology
- Imaging
- Immunotherapies
- Industrial automation and materials processing
- Industrial hygiene
- Laboratory equipment
- Manufacturing & control systems
- Manufacturing & packaging
- Medical device coatings
- Metabolomics
- Microbiology
- Microbiome therapies
- Microfluidic devices
- Microfluidics
- Multiplex assays
- Nanotechnology
- Next generation sequencing
- NMR devices
- Nucleic acids
- Nutraceuticals
- Orthopedic devices
- Peptides
- Pharmaceuticals
- Plant and agricultural technology
- Plastics and polymer science
- Proteomics
- Repurposed drugs
- Sequencing equipment
- Stem cell technology
- Therapeutic methods
- Ultrasound and thermoacoustic imaging